Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.
The news comes as the United States approaches 300,000 deaths from COVID-19.
Pharma major Ranbaxy Laboratories has set aside Rs 257.4 crore (Rs 2.57 billion) towards the financial impact of a US ban on import of products made at its plant at Toansa.
Guterres reiterated his call for a COVID-19 vaccine to be a global public good available to everywhere and particularly, available in Africa.
The first drug to treat low sexual desire in premenopausal women, dubbed "female Viagra", has been approved in the United States, but with a warning about potentially dangerous side effects such as severe low blood pressure and fainting.
In India, thousands of lives are lost every year because of unavailability of organs
Facing accusations of delay in placing orders for vaccines, the government on Thursday defended its vaccine procurement policy saying it has been pursuing Pfizer, J&J and Moderna since mid-2020 for the earliest possible imports, and has even waived local trials for well-established foreign vaccine makers.
Calling for 'equal recognition of vaccines', COVAX on Thursday urged all governments to recognise as 'fully vaccinated' those people who have received COVID-19 vaccines deemed safe by World Health Organisation, saying any move that restricts travel of people based on the vaccines they have received is 'counter-effective, both in spirit and outcome'.
'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'
This time food regulators found excess presence of ash content in Maggi
Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.
The company has not yet revealed details about the unexplained illness but has stopped trials while doctors find out if the illness was caused due to the vaccine or was a coincidence.
'In the likelihood that Omicron is circulating, you have a much greater chance of getting infected now, than you did during the Age of Delta.'
On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.
A single-member commission under retired judge Anita Jha was constituted on Firday to probe the botched sterilisation surgeries at Bilaspur's government-run medical camps, which have so far claimed lives of 13 young women and left nearly 138 ill, and asked to submit its report within three months.
The company has launched only 3 new products during 2015 when compared to 14 launches in 2014
Fast Moving Consumer Goods major Nestle may face more action by the Uttar Pradesh Food Safety and Drug Administration, which is testing more batches of Maggi after ordering recall of a batch of about 2 lakh packs of the instant noodles due to higher than permitted levels of lead and a food additive.
The meetings were a sign of crisis management.
The test named the "SARS-CoV-2 DETECTR" is easy to implement and to interpret, and requires no specialised equipment, said researchers from the University of California, San Francisco in the US.
The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.
OBC leader Dharam Singh Saini on Thursday became the third minister to resign from the Uttar Pradesh cabinet this week, giving yet another jolt to the ruling Bharatiya Janata Party in the run-up to the assembly polls.
A case was lodged on Saturday against Nestle India in a local court here over safety standards of its Maggi product, while actors Amitabh Bachhan, Madhuri Dixit and Preity Zinta have also been separately dragged to the court for promoting the 'two-minute' noodles brand.
Credit Suisse analysts cut their rating on Sun Pharma stock to 'neutral' from 'outperform
If the company manages to get a go-ahead from the regulator for this plant, it might result in resumption of supplies of several of their products, barred from the US last year.
The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.
With this allocation of portfolios, the Sharad Pawar-led NCP has got most of the 'plum' ministries.
"Due to scheduling reasons, it is inconvenient for China to attend the meeting," Chinese Foreign Ministry spokesman Wang Wenbin told mediapersons.
At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield.
At least 85 people have died of coronavirus with the confirmed cases crossing 4,500 in the US.
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
The US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products
'The Centre and state need to take a unified approach and take concerted action before this matter assumes menacing proportions because unemployment, the drug trade and the levels of frustration among the youth make them vulnerable to any maverick who promises something better.'
The vaccine arrives at a critical moment for the US. Hospitalisations due to COVID-19 hit record highs for the seventh day in a row on Saturday.
These vaccines have not yet been approved by the World Health Organization
The merger has fortified Sun Pharma's position.
Trump also raised the possibility of using light to combat the deadly viral infection.
The US Food and Drug Administration said on Sunday that over 70,000 patients in the country had been treated with convalescent plasma, which is made using the blood of people who have recovered from coronavirus infections.
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
Nestl India is preparing a blueprint for a possible relaunch.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances